The next-generation sequencing (NGS) global market is projected to reach $14,722.5 million by 2022, driven by advancements in DNA sequencing technologies and increased applications in diagnostics, drug discovery, and genomic research. The report details market segmentation by technology, product, application, and geography, highlighting the growth opportunities and challenges in standardization and data interpretation. Major players include Agilent Technologies, Illumina, and Thermo Fisher Scientific, with North America being the leading market due to its advanced healthcare framework and significant R&D investment.

1. IQ4I Research & Consultancy Pvt. Ltd. Page 1
Next-Generation Sequencing (NGS) Global Market
–Forecast to 2022
Next-generation Sequencing (NGS) Global Market estimated to be worth
$14,722.5 million by 2022
IQ4I Research & Consultancy published a new report on “Next-Generation
Sequencing (NGS) Global Market – Forecast To 2022” This report analyzes and studies
the overall market, major drivers & Opportunities, Restraints & Threats in North America,
Europe, Asia-Pacific and Rest of the World
IQ4I’s Report Contains 112 market data tables and 69 figures spread through 375
pages and an exhaustive TOC on “Next-Generation Sequencing (NGS) Global
Market [Technology (Reversible terminator Sequencing, Ion-Semiconductor sequencing,
Sequencing by Ligation, Single-Molecule Real-time (SMRT) Sequencing and others),
Products (Instruments, Services and Work-flow products), , Application (By Process and By
field) (By Process- Genomics, Epigenomics, Transcriptomics and Others & By field-
Diagnostics, Drug discovery and development, Biomarker discovery, Agriculture and
animal research and Others), End-Users (Academic Research, Hospitals and clinics,
Biotech/Pharmaceuticals and Others) Region [(North America (U.S. and Others), Europe
(U.K., Germany, Spain and Others), APAC(South Korea, China, Australia and others) and
ROW(Brazil, South Africa, Middle East and Others)]
This report analyzes the Next-Generation Sequencing global market in terms of market
revenue ($ million) for all segments and it enables Next-Generation Sequencing
stakeholders such as NGS service providers, diagnostic testing and monitoring service
centers, clinical laboratories & hospitals, pharma & biotech Companies, Various research
and consulting firms to identify and analyze market expansion opportunities, technological
advancements and competition in Next-Generation Sequencing global market.
Next-generation sequencing refers to modern non-Sanger-based high-throughput DNA
sequencing technologies that can sequence millions or billions of DNA strands in parallel,
yielding substantially more throughput and minimizing the need for the time consuming
fragment-cloning methods that are often used in Sanger sequencing of genomes. Next-
generation sequencing market is a fast emerging market with a high growth rate, as
estimated by IQ4I Research that the Next-generation sequencing global market are
expected to grow at a high double-digit CAGR from 2015-2022.
Reduced cost and high speed of NGS technology, increased usage in the clinical segment,
new application areas of NGS and switch over from microarrays to NGS, are expected to
propel the growth of next-generation sequencing market. However some issues like
standardization of NGS for clinical use, complexity in data interpretation, shortage of skilled

2. IQ4I Research & Consultancy Pvt. Ltd. Page 2
Next-Generation Sequencing (NGS) Global Market
–Forecast to 2022
labor and dependence on grants and funding for NGS infrastructure may hinder the growth
of next-generation sequencing market.
The Next-generation sequencing global market by technology is segmented into Reversible
terminator sequencing, Ion semi-conductor sequencing, Sequencing by Ligation (SBL),
Single-Molecule Real-time (SMRT) Sequencing and others. The Reversible terminator
sequencing occupied highest market in Next-generation sequencing technology market. The
Next-generation sequencing global market by products is segmented into Instruments,
Services and Work-flow products. The services market is further segmented into Data
analysis services and Sequencing Services. The Services segment is estimated to grow at
strong CAGR from 2015 to 2022.
The Next-generation sequencing global market by Application is segmented based on
process and field of application. By process, the market is segmented into Genomics,
Epigenomics, Transcriptomics and others. Genomics application is further segmented into
Whole genome sequencing, Exome sequencing, Targeted sequencing and De Novo
sequencing). Epigenomics market is further segmented into ChiP sequencing and
Methylation sequencing). By field of application, the market is segmented into Diagnostics,
Drug discovery and development, Biomarker discovery, Agriculture and animal research and
others. Diagnostics application is further segmented into Cancer diagnostics, Infectious
disease diagnostics, Genetic analysis and Transplantation diagnostics. The Diagnostics
application occupied highest market in Next-generation sequencing application market. The
End-users consists of Academic Research, Hospitals and clinics, Biotech/Pharmaceuticals
and Others. The Academic Research contributed the largest revenue as per estimates of
IQ4I Research.
The Next-generation sequencing global market based on geography is divided into North
America, Europe, Asia-Pacific and Rest of the world. North American region commanded the
largest revenue in 2015 due to advanced technological healthcare framework, rise in growth
of personalized medicine, increasing incidence of infectious disease and cancer, high R&D
investment for genomic and proteomic sequence determination for biomarker and drug
discovery research.
Some of the prominent players in next-generation sequencing market include Agilent
Technologies (U.S.), BGI (China), Illumina, Inc. (U.S.), Pacific Biosciences of California, Inc.
(U.S.), Qiagen N.V. (Netherlands), Oxford Nanopore Technologies Ltd. (U.K.), Eurofins

3. IQ4I Research & Consultancy Pvt. Ltd. Page 3
Next-Generation Sequencing (NGS) Global Market
–Forecast to 2022
Scientific (U.K.), Roche holdings AG (Switzerland), DNASTAR, Inc. (U.S.), Thermo Fischer
Scientific, Inc.(U.S).
Reasons for buying this report:
 Analysis of the Next-generation sequencing global market by identifying various
segments by technology, product type, applications, end users and geography.
 Revenue forecast of the Next-generation sequencing market and strategic analysis of
each submarket with respect to segmental growth trends.
 Analysis of the major market trends and factors driving or inhibiting the growth of the
Next-generation sequencing global market.
 Revenue forecast of the NGS market with respect to North America (U.S. and
others), Europe (U.K., Germany, Spain and Others), Asia-Pacific (China, South
Korea, Australia and others) and the Rest of the World (RoW) (Brazil, Middle East,
South Africa and Others).
 Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
 Analysis of country wise installation base.
 Identification of key technology developments and innovations driving the market.
 Profiles of major players in the next-generation sequencing global market with details
of their product offerings, business strategies, market shares and patent application
filing trends.
 Established and Emerging players (47 companies) and their product offerings.

4. IQ4I Research & Consultancy Pvt. Ltd. Page 4
Next-Generation Sequencing (NGS) Global Market
–Forecast to 2022
FIGURE 1
NEXT-GENERATION SEQUENING GLOBAL MARKET SEGMENTATION
Next-Generation Sequencing (NGS) Global Market
By Technique
Reversible Terminator
Sequencing
By Product By End-Users
Ion Semiconductor
sequencing
Sequencing by
Ligation
Instruments
Work flow products
Academic
research
Hospitals
Biotech/Pharma
SMRTSequencing
Others
Services
DataAnalysis
Services
Sequencing
Services
By Application
By processBy Field
Diagnostics
Drug Discovery &
Development
Biomarker
discovery
Agriculture & animal
health
Others
Epigenomics
Genomics
Transcriptomics
Others
Cancer diagnostics
Transplant dgx
Genetic analysis
Infectious diseases
WGS
Targeted sequencing
Exome sequencing
De-novo sequencing
Methyl sequencing
ChIP Sequencing
Others